News
The incidence of cyanotic congenital heart disease increased in states with restrictive abortion policies after the Dobbs ...
The risk for subsequent stroke is persistently high for patients who have had a transient ischemic attack (TIA) or minor stroke.
In the SmartfIRE study, the Thermocool Smarttouch SF catheter showed an 86.9% effectiveness rate among patients treated with high adherence to recommended ablation parameters.
10d
MedPage Today on MSNPulsed Field Ablation an Option to Prevent Recurrence of Atrial TachyarrhythmiaPulsed field ablation (PFA) was noninferior to cryoballoon ablation for the incidence of a first recurrence of atrial ...
Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...
Some people may experience mild symptoms of PNH for decades. The mortality rates with PNH are typically 35% at 5 years and 50% at 10 years. The gene mutation that causes PNH occurs in several steps.
We report a case of Primaquine (PQ) induced hemoglobinuria in a patient with the glucose-6-phosphate dehydrogenase (G6PD) Mahidol variant from Bandarban, Bangladesh. The patient presented with mixed ...
The Elementary to Postsecondary Student Education Dashboard: Enrolments, Graduations and Tuition Fees comprehensive data visualization tool overviews counts of enrolments and graduations for ...
Capital city growth comprised overseas migration (373,000), natural increase (89,500) and internal migration (-34,600). Melbourne had the largest increase (142,600), Perth had the highest growth rate ...
If approved, crovalimab would be the first PNH drug that could be given by subcutaneous injection once a month outside a supervised healthcare setting, setting up a challenge to AstraZeneca's ...
It acquired Solvvy in May 2022, which sells conversational AI and automation packages to customer support centres. We have collected data and statistics on Zoom. Read on below to find out more.
The first is for Soliris, a medicine for a rare blood disease called paroxysmal nocturnal hemoglobinuria. The second is for Brilinta, a treatment used to reduce the risk of heart attacks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results